本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akero Therapeutics

53.84
+0.18000.34%
盘后53.890.0500+0.09%19:52 EDT
成交量:157.62万
成交额:8,468.68万
市值:43.07亿
市盈率:-14.24
高:53.87
开:53.67
低:53.63
收:53.66
52周最高:58.40
52周最低:21.34
股本:7,998.90万
流通股本:6,777.24万
量比:0.33
换手率:2.33%
股息:- -
股息率:- -
每股收益(TTM):-3.7801
每股收益(LYR):-3.7544
净资产收益率:-31.14%
总资产收益率:-20.36%
市净率:4.20
市盈率(LYR):-14.34

数据加载中...

2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

重要事件披露

Form 8-K - Current report
2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/17

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]